- Home
- NVCR vs CPRI Comparison
NVCR vs CPRI Comparison
Compare NVCR & CPRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVCR | CPRI |
|---|---|---|
| Founded | 2000 | 1981 |
| Country | Switzerland | United Kingdom |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.4B |
| IPO Year | 2015 | 2011 |
Fundamental Metrics
Financial Performance| Metric | NVCR | CPRI |
|---|---|---|
| Price | $14.70 | $15.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 16 |
| Target Price | ★ $26.86 | $22.22 |
| AVG Volume (30 Days) | 1.2M | ★ 3.8M |
| Earning Date | 10-29-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 21.79 | ★ 111.40 |
| EPS | N/A | ★ 0.60 |
| Revenue | $655,353,000.00 | ★ $3,474,000,000.00 |
| Revenue This Year | $10.80 | N/A |
| Revenue Next Year | $10.83 | $2.79 |
| P/E Ratio | ★ N/A | $24.88 |
| Revenue Growth | ★ 8.28 | N/A |
| 52 Week Low | $9.82 | $12.40 |
| 52 Week High | $21.45 | $28.27 |
Technical Indicators
Market Signals| Indicator | NVCR | CPRI |
|---|---|---|
| Relative Strength Index (RSI) | 37.07 | 57.72 |
| Support Level | $13.12 | $14.99 |
| Resistance Level | $15.19 | $16.05 |
| Average True Range (ATR) | 0.62 | 0.60 |
| MACD | -0.12 | 0.05 |
| Stochastic Oscillator | 29.51 | 58.24 |
Price Performance
Historical ComparisonAbout NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.
About CPRI Capri Holdings Limited
Capri Holdings is a marketer, distributor, and retailer of upscale accessories and apparel in the Americas, Europe, and Asia. Michael Kors, Capri's original and largest brand by sales, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. Its products are sold in more than 200 company-operated stores. John Idol has served as Capri's CEO since 2003.